Veterans Affairs Medical Center-San Francisco

San Francisco, California 94121

3 studies enrolling now · 98 studies all time

What they study most

ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Adenocarcinoma of the Prostate, Advanced Lung Non-Small Cell Carcinoma, Atrial Fibrillation, Bladder Cancer, Breast Cancer, Cervical Cancer, Childhood Germ Cell Tumor, Colorectal Cancer, Diarrhea

Studies at this site

• Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) — Recruiting now
• Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial) — Recruiting now
• Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer — Recruiting now
• Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors — Recruiting now
• Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial) — Recruiting now
• Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) — Running, not enrolling
• Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer — Running, not enrolling
• S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer — Running, not enrolling
• Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery — Completed
• Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) — Running, not enrolling
• The National Myelodysplastic Syndromes (MDS) Study — Completed
• Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) — Running, not enrolling
• Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) — Running, not enrolling
• Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer — Withdrawn before enrolling
• Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer — Status unconfirmed
• Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer — Completed
• Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium — Completed
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia — Completed
• Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes — Completed
• Combination Chemotherapy in Treating Women With Breast Cancer — Completed
• S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer — Completed
• Semaglutide to Reduce Atrial Fibrillation Burden — Paused
• The National CT Colonography Trial — Completed
• Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer — Completed
• Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy — Completed
• Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer — Stopped early
• FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum — Stopped early
• Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer — Stopped early
• Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Completed
• Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer — Completed
• Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery — Completed
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer — Completed
• Topotecan in Treating Patients With Myelodysplastic Syndrome — Completed
• Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer — Completed
• Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer — Completed
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma — Completed
• Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer — Completed
• Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma — Completed
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer — Completed
• Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma — Completed
• Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer — Completed
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer — Completed
• Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver — Completed
• Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer — Completed
• Capecitabine in Treating Patients With Malignant Mesothelioma — Completed
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma — Completed
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma — Completed
• Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia — Completed
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer — Completed
• Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas — Completed